- Home
- IDE vs TVGN Comparison
IDE vs TVGN Comparison
Compare IDE & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDE
- TVGN
- Stock Information
- Founded
- IDE 2010
- TVGN 2020
- Country
- IDE United States
- TVGN United States
- Employees
- IDE N/A
- TVGN N/A
- Industry
- IDE Finance/Investors Services
- TVGN Blank Checks
- Sector
- IDE Finance
- TVGN Finance
- Exchange
- IDE Nasdaq
- TVGN Nasdaq
- Market Cap
- IDE 177.2M
- TVGN 193.1M
- IPO Year
- IDE N/A
- TVGN N/A
- Fundamental
- Price
- IDE $11.59
- TVGN $1.21
- Analyst Decision
- IDE
- TVGN Strong Buy
- Analyst Count
- IDE 0
- TVGN 1
- Target Price
- IDE N/A
- TVGN $10.00
- AVG Volume (30 Days)
- IDE 33.5K
- TVGN 429.6K
- Earning Date
- IDE 01-01-0001
- TVGN 08-13-2025
- Dividend Yield
- IDE 8.83%
- TVGN N/A
- EPS Growth
- IDE N/A
- TVGN N/A
- EPS
- IDE N/A
- TVGN N/A
- Revenue
- IDE N/A
- TVGN N/A
- Revenue This Year
- IDE N/A
- TVGN N/A
- Revenue Next Year
- IDE N/A
- TVGN N/A
- P/E Ratio
- IDE N/A
- TVGN N/A
- Revenue Growth
- IDE N/A
- TVGN N/A
- 52 Week Low
- IDE $8.61
- TVGN $0.26
- 52 Week High
- IDE $10.46
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- IDE 63.98
- TVGN 49.84
- Support Level
- IDE $11.30
- TVGN $1.19
- Resistance Level
- IDE $11.74
- TVGN $1.27
- Average True Range (ATR)
- IDE 0.08
- TVGN 0.05
- MACD
- IDE -0.02
- TVGN -0.00
- Stochastic Oscillator
- IDE 79.55
- TVGN 57.14
About IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest
Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.